SYNOVAN INJECTION FOR DOGS

国: オーストラリア

言語: 英語

ソース: APVMA (Australian Pesticides and Veterinary Medicines Authority)

即購入

ダウンロード 製品の特徴 (SPC)
01-07-2013

有効成分:

ACETYL GLUCOSAMINE; PENTOSAN POLYSULFATE SODIUM

から入手可能:

CEVA ANIMAL HEALTH PTY LTD

INN(国際名):

sodium pentosan polysulfate(100mg/mL)+acetyl glucosamine(160mg/mL)

医薬品形態:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

構図:

ACETYL GLUCOSAMINE CARBOHYDRATE-GLUCOSE Active 160.0 mg/ml; PENTOSAN POLYSULFATE SODIUM MINERAL-SODIUM Active 100.0 mg/ml

パッケージ内のユニット:

1/20mL; 1x10mL; 6x20mL

クラス:

VM - Veterinary Medicine

製:

CEVA ANIMAL HEALTH

治療群:

DOG | BITCH | CASTRATE | PUPPY

治療領域:

MUSCULOSKELETAL SYSTEM

適応症:

INFLAMMATORY JOINT DISEASE | NON-INFECTIOUS JOINT DISEASE

製品概要:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [INFLAMMATORY JOINT DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [INFLAMMATORY JOINT DISEASE]; An aid in the treatment of non-infectious inflammatory joint disease in dogs.Contraindicated for use in dogs with clotting defects, traumatic haemorrhage, infection, liver/kidney failure, or within 2 days of surgery.

認証ステータス:

Registered

承認日:

2023-07-01

情報リーフレット

                                _carton _
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH
OF
CHILDREN
FOR ANIMAL TREATMENT ONLY
SYNOVAN™
INJECTION FOR DOGS
ACTIVE CONSTITUENTS:
PENTOSAN POLYSULFATE SODIUM
100 mg/mL
ACETYL GLUCOSAMINE
160
mg/ml
AN AID
IN
THE TREATMENT
OF
NON-
INFECTIOUS, INFLAMMATORY JOINT
DISEASE
IN
DOGS.
[10
mL,
20
mL,
6 X 20 mL]
READ
THE
ENCLOSED
LEAFLET
BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE:
Contraindicated
for
use
in
dogs
with
clotting
defects,
traumatic
haemorrhage,
infection,
liver/kidney
failure,
or
within
2
days
of
surgery.
Safety studies on the product
in
dogs have
been done at
up
to
3x
recommended dose
rate,
at weekly
intervals
for six weeks.
Safety studies have not been carried out
for longer term
use.
Safety studies have
not been carried out
in
pregnant, breeding
or lactating animals. Use of the product
in
these
groups
of
animals
is
not
recommended.
A
dose
dependent
increase
in
activated partial thromboplastin
time (aPTT) was
seen
during the safety
trials but levels returned to normal within
24 hours post treatment. The prescribing
veterinarian should consider this where the
patient may have suspected or diagnosed
disorders that may affect haemostasis, or
HAVE
CONCURRENT
MEDICATIONS
THAT
AFFECT
HAEMOSTASIS.
THERE
WAS
NO
SIGNIFICANT
difference between pre-trial and post-trial
aPTT levels.
ADMINISTER
BY
INTRAMUSCULAR
or
Store
below
25"C
(Air
conditioning).
SUBCUTANEOUS
INJECTION.
Do
not freeze. Protect from Light.
DOSE RATE:
B:
Use the contents of the vial within 3 months
Exp :
of
initial broaching, and discard any unused
portion.
~PVMA
Approval No.: 63093/55738
0.3 mU1 0
kg
(3
mg/kg Pentosan polysulfate
sodium, 4.8 mg/kg Acetyi-Giucosamine) on
four occasions with an interval
of
5-7 days
BETWEEN
INJECTIONS.
FIRST AID:
If poisoning occurs, contact a
doctor or Poisons Information Centre
(Phone Australia 131126; NZ 0800
764766).
Dispose
of
empty
container
and
outer
packaging
by
wrapping
with
paper
and
putting
in
garbage.
+
RLP
Approved
Product
of
Australia
Ceva Animal Health Pty
Ltd
11
Moores
Rd
Glenorie NSW 2157

                                
                                完全なドキュメントを読む
                                
                            

製品の特徴

                                SYNOVAN Injection for Dogs 
 
Creation Date: 1 October 2007 
Revision Date: 27 April 2011 
Version: 3   
Next revision due: April 2016 
 
 
 
MATERIAL SAFETY DATA SHEET 
_SYNOVAN INJECTION FOR DOGS_
 
Page 1 of 9 
 
 
 
 
 
COMPANY DETAILS 
 
COMPANY: 
 
 
 
 
 
ADDRESS: 
Ceva Animal Health Pty Ltd 
 
 
 
11 Moores Road 
ABN 54 002 692 426    
 
 
 
Glenorie   NSW   2157  Australia 
 
 
 
 
 
 
 
 
TELEPHONE NUMBER:   
 
 
 
FACSIMILE NUMBER: 
+61 (02) 9652 7000 
 
 
 
 
+61 (02) 9652 7001 
 
EMERGENCY TELEPHONE NUMBER: 
+61 (02) 9652 7000 (Business Hours) 
Poisons Information Centre: 131126 
 
SUBSTANCE IDENTIFICATION 
 
PRODUCT NAME: 
_SYNOVAN Injection for Dogs. _
 
OTHER NAMES: 
_PPS / NAG Injection for Dogs _
 
MANUFACTURER’S PRODUCT CODE: 
ISYN. 
 
UN NUMBER: 
None allocated 
 
DANGEROUS GOODS CLASS AND SUBSIDIARY RISK: 
None allocated 
 
HAZCHEM CODE: 
None allocated 
 
SUSDP POISONS SCHEDULE NUMBER: 
S4 
 
USE: 
An aid in the treatment of non-infectious joint disease
in dogs. For animal treatment only. 
 
 
 
 
 
STATEMENT OF HAZARDOUS NATURE: 
Hazardous according to criteria of NOHSC Australia. 
 
RISK PHRASES: 
SECTION 1 – IDENTIFICATION OF MATERIAL AND SUPPLIER 
SECTION 2 – HAZARDS IDENTIFICATION 
SYNOVAN Injection for Dogs 
 
Creation Date: 1 October 2007 
Revision Date: 27 April 2011 
Version: 3   
Next revision due: April 2016 
 
 
 
MATERIAL SAFETY DATA SHEET 
_SYNOVAN INJECTION FOR DOGS_
 
Page 2 of 9 
 
None. 
 
SAFETY PHRASES: 
None. 
 
 
 
 
 
The substance is a complex mixture, including the following
ingredients.  
 
INGREDIENTS: 
CHEMICAL NAME 
CAS NUMBER 
PROPORTION 
* Acetyl glucosamine 
 
(N-aceylglucosamine) 
7512-17-6 
[http://www.emolecules.com/cgi-bin/search?t=ss&q=7512-17-6&c=0&v=]
  16% 
* Pentosan Polysulphate 
37
                                
                                完全なドキュメントを読む
                                
                            

ドキュメントの履歴を表示する